AR and prostate carcinoma: Prostate cancer was androgen-dependent and relied on the androgen receptor (AR) to mediate the actions of androgens, with the AR being expressed in development.95 Androgen deprivation treatment had been used to decrease androgen-dependent prostate cancer cell proliferation, mainly in the metastatic stage.